Claritev initiated with an Equal Weight at Wells Fargo

Wells Fargo analyst Stan Berenshteyn, initiated coverage of Claritev (CTEV) with an Equal Weight rating and $33 price target The company is an “entrenched strategic vendor” to payers with accelerating revenue, but its elevated leverage “makes it hard to justify a premium valuation,” the analyst tells investors in a research note.